Corrigendum to "Early detection of wearing off in Parkinson disease: The DEEP study" [Parkinsonism Relat Disorder, 20, (2014), 204-211], doi: 10.1016/j.parkreldis.2013.10.027;Early DEtection of wEaring off in Parkinson disease: The DEEP study

Parkinsonism and Related Disorders

Volumn 20, Issue 2, 2014, Pages 204-211

  Stocchi, F ^a   Antonini, A ^b   Barone, P ^c   Tinazzi, M ^d   Zappia, M ^e   Onofrj, M ^f   Ruggieri, S ^g   Morgante, L ^h   Bonuccelli, U ⁱ   Lopiano, L ^j   Pramstaller, P ^k   Albanese, A ^l   Attar, M ^m   Posocco, V ^m   Colombo, D ^m   Abbruzzese, G ⁿ   DEEP study group, ^o  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

^e Clinica Neurologica I Policlinico Universitario   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

^g IRCCS NEUROMED   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ Ospedale Versilia   (Italy)

^j Neurologia 4 ASO Molinette   (Italy)

^k Ospedale di Bolzano   (Italy)

^l UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^m Medical Department   (Italy)

ⁿ UNIVERSITY OF GENOA   (Italy)

^o NONE

more..

Author keywords

Parkinson's disease; Quality of life; Wearing off; Wearing off questionnaire

Indexed keywords

LEVODOPA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFECT; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TREATMENT DURATION; UNIFIED PARKINSON DISEASE RATING SCALE; VERY ELDERLY; WEARING OFF PHENOMENON;

PARKINSON'S DISEASE; QUALITY OF LIFE; WEARING-OFF; WEARING-OFF QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84893681784     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.04.021     Document Type: Erratum

References (29)

1. Schrag A., Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000, 123:2297-2305.
2. Sethi K.D. The impact of levodopa on quality of life in patients with Parkinson disease. Neurologist 2010, 16:76-83.
3. Stacy M., Bowron A., Guttman M., Hauser R., Hughes K., Larsen J.P., et al. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord 2005, 20:726-733.
4. Stacy M. The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease. JNeural Transm 2010, 117:837-846.
5. Silburn P.A., Mellick G.D., Vieira B.I., Danta G., Boyle R.S., Herawati L. Utility of a patient survey in identifying fluctuations in early stage Parkinson's disease. JClin Neurosci 2008, 15:1235-1239.
6. Martinez-Martin P., Tolosa E., Hernandez B., Badia X. ValidQUICK Study Group. Validation of the "QUICK" questionnaire-a tool for diagnosis of "wearing-off" in patients with Parkinson's disease. Mov Disord 2008, 23:830-836.
7. Antonini A., Martinez-Martin P., Chaudhuri R.K., Merello M., Hauser R., Katzenschlager R., et al. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord 2011, 26:2169-2175.
8. Abbruzzese G., Antonini A., Barone P., Stocchi F., Tamburini T., Bernardi L., et al. Linguistic, psychometric validation and diagnostic ability assessment of an italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. Neurol Sci 2012, 33:1319-1327.
9. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
10. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hayman N. The PDQ-8: development and validation of a short-form Parkinson's Disease Questionnaire. Psychol Health 1997, 12:805-814.
11. Bareš M., Rektorová I., Jech R., Farníková K., Roth J., Růžička E., et al. Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?. JNeural Transm 2012, 119:373-380.
12. Marsden C.D., Parkes J.D. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1977, 1:345-349.
13. Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001, 16:448-458.
14. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996, 39:37-45. Parkinson Study Group.
15. Fahn S., Oakes D., Shoulson I., Kieburtz K., Rudolph A., Lang A., et al. Levodopa and the progression of Parkinson's disease. NEngl J Med 2004, 351:2498-2508.
16. Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease?. JNeurol 2005, 252:IV37-IV42. the Parkinson Study Group.
17. Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. Parkinson Study Group. JAm Med Assoc 2000, 284:1931-1938. Parkinson Study Group.
18. Sato K., Hatano T., Yamashiro K., Kagohashi M., Nishioka K., Izawa N., et al. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 2006, 21:1384-1395.
19. Stocchi F. Prevention and treatment of motor fluctuations. Parkinsonism Relat Disord 2003, 9:S73-S81.
20. Adler C.H. Relevance of motor complications in Parkinson's disease. Neurology 2002, 58:S51-S56.
21. Witjas T., Kaphan E., Azulay J.P., Blin O., Ceccaldi M., Pouget J., et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002, 59:408-413.
22. Politis M., Wu K., Molloy S., G Bain P., Chaudhuri K.R., Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010, 25:1646-1651.
23. Weintraub D., Moberg P.J., Duda J.E., Katz I.R., Stern M.B. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. JAm Geriatr Soc 2004, 52:784-788.
24. Stacy M.A., Murphy J.M., Greeley D.R., Stewart R.M., Murck H., Meng X., et al. The sensitivity and specificity of the 9-item wearing-off Questionnaire. Parkinsonism Relat Disord 2008, 14:205-212.
25. Melo L.M., Chien H.F., Barbosa E.R. Identification of wearing-off manifestations (reduction of levodopa effect) in Parkinson's disease using specific questionnaire and comparison of the results with routine ambulatory evaluations. Arq Neuropsiquiatr 2010, 68:506-510.
26. Hassin-Baer S., Molchadski I., Cohen O.S., Nitzan Z., Efrati L., Tunkel O., et al. Gender effect on time to levodopa-induced dyskinesias. JNeurol 2011, 258:2048-2053.
27. Nissinen H., Kuoppamäki M., Leinonen M., Schapira A.H. Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson's disease: a long-term, retrospective analysis. Eur J Neurol 2009, 16:1305-1311.
28. Fung V.S., Herawati L., Wan Y. Movement disorder Society of Australia clinical research and trials group; QUEST-AP Study Group. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone. Mov Disord 2009, 24:25-31.
29. Antonini A., Chaudhuri K.R., Martinez-Martin P., Odin P. Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease. CNS Drugs 2010, 24:119-129.